Related Experiment Videos
Nephrotoxicity of gentamicin. Action on subcellular organelles and pharmacokinetics in the kidney
Abstract:
Our findings on the renal pharmacokinetics of gentamicin explain why: (1) gentamicin concentrations in the kidney reach levels high enough to provoke injuries to the organelles; (2) the morphological manifestations of toxicity involve primarily the convoluted proximal tubule (which constitutes the largest part of the cortex), since antibiotic concentrations in this area are especially high; (3) nephrotoxicity is related to duration of treatment; (4) urine may contain small quantities of gentamicin up to 3 weeks after the end of therapy (14, 22, 30); (5) nephrotoxicity continues after discontinuance of the treatment, and (6) the hepatocytes, whose lysosomes are very sensitive to the action of gentamicin, show no obvious signs of toxicity, since the antibiotic never attains a high enough concentration in this organ.
Insights
Gentamicin accumulates in kidney tubules, causing damage and toxicity that persists after treatment. This explains why the kidneys are susceptible to gentamicin
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Gentamicin is an antibiotic commonly used to treat bacterial infections.
- Nephrotoxicity is a known side effect of gentamicin therapy.
- Understanding the renal pharmacokinetics of gentamicin is crucial for managing its toxicity.
Purpose of the Study:
- To elucidate the renal pharmacokinetic properties of gentamicin.
- To explain the mechanisms underlying gentamicin-induced nephrotoxicity.
- To correlate gentamicin concentrations in renal tissues with observed toxic effects.
Main Methods:
- Analysis of renal pharmacokinetics of gentamicin.
- Correlation of tissue concentrations with morphological changes.
- Assessment of gentamicin levels in urine post-treatment.
Main Results:
- Gentamicin concentrations in the kidney reach levels sufficient to cause organelle injury.
- The convoluted proximal tubule exhibits the highest antibiotic concentrations and primary toxicity.
- Nephrotoxicity is directly related to treatment duration and can persist after therapy cessation.
- Detectable gentamicin levels in urine persist for up to 3 weeks post-therapy.
Conclusions:
- Renal pharmacokinetics of gentamicin explain its nephrotoxic potential.
- Proximal tubule damage is linked to high gentamicin accumulation.
- Persistent nephrotoxicity and urinary excretion highlight the need for careful gentamicin monitoring.